To identify Cav1 as an important negative regulator in the process of liver fibrosis, we delivered CSD to WT and Cav1−/− animals following CCl4 treatment and assessed whether CSD could inhibit the progress of fibrosis. This evidence concerns the gene CAV1 and Hepatic fibrosis.